Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001989993 | SCV002228583 | uncertain significance | not provided | 2022-10-28 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 1450144). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 977 of the EPHB4 protein (p.Pro977Leu). This variant is present in population databases (rs773050327, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with EPHB4-related conditions. |
Ambry Genetics | RCV004043948 | SCV004866211 | likely benign | Cardiovascular phenotype | 2024-01-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |